{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:53:16Z","timestamp":1784227996572,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12350-020-02359-y","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T19:04:50Z","timestamp":1601492690000},"page":"753-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis"],"prefix":"10.1016","volume":"29","author":[{"given":"Mana","family":"Okune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kagioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02359-y_bib1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1007\/s12350-020-02359-y_bib2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","article-title":"A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy","volume":"150","author":"Ardehali","year":"2005","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-020-02359-y_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1007\/s12350-020-02359-y_bib4","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis-digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1007\/s12350-020-02359-y_bib5","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02359-y_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02359-y_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000437","article-title":"Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis","volume":"3","author":"Yasuda","year":"2016","journal-title":"Open Heart"},{"key":"10.1007\/s12350-020-02359-y_bib8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1007\/s00392-019-01591-y","article-title":"Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: Analysis by cardiac magnetic resonance imaging","volume":"109","author":"Kagioka","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1007\/s12350-020-02359-y_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02359-y_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-020-02359-y_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008975","article-title":"Diagnostic accuracy of advanced imaging in cardiac sarcoidosis","volume":"12","author":"Divakaran","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02359-y_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02359-y_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02359-y_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02359-y_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11886-013-0370-6","article-title":"18F-FDG PET\/CT for the assessment of myocardial sarcoidosis","volume":"15","author":"Skali","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"10.1007\/s12350-020-02359-y_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-020-02359-y_bib17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-020-02359-y_bib18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02359-y_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lungcan.2018.05.001","article-title":"Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung","volume":"121","author":"Furumoto","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1007\/s12350-020-02359-y_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-020-02359-y_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1532-429X-12-71","article-title":"Cardiovascular magnetic resonance physics for clinicians: Part I","volume":"12","author":"Ridgway","year":"2010","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-020-02359-y_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","article-title":"Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping","volume":"189","author":"Crouser","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1007\/s12350-020-02359-y_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2015.05.075","article-title":"Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis","volume":"195","author":"Yokoyama","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-020-02359-y_bib24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovascular Imaging"},{"key":"10.1007\/s12350-020-02359-y_bib25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on (18)F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovascular Imaging"},{"key":"10.1007\/s12350-020-02359-y_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02359-y_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovascular Imaging"},{"key":"10.1007\/s12350-020-02359-y_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2018.09.015","article-title":"Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis","volume":"74","author":"Sgard","year":"2019","journal-title":"Clin Radiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02359-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123002817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123002817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02359-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:37Z","timestamp":1761027097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123002817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1071358123002817"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02359-y","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02359-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}